Christos Shammas - Genetic Mutations

Author Information

Christos Shammas is a distinguished researcher affiliated with the Genetics Department at AVVA Pharmaceuticals Ltd, located in Limassol, Cyprus. His work primarily focuses on genetics, with a diverse range of research interests that span microbiome studies, genetic mutations, and the treatment of various medical conditions. His affiliation with a prominent pharmaceutical company underscores his involvement in applied genetic research and its implications in medical science.

Research Contributions

Christos Shammas has made significant contributions to the field of genetics, particularly in understanding the genetic and microbiome factors associated with various health conditions. His research includes the study of prokaryotic colonization of environmental plastics, the role of Bifidobacterium in the gut microbiome of women with polycystic ovary syndrome, and the genetic underpinnings of hyperandrogenemia and central precocious puberty. By exploring both environmental and genetic factors, Shammas's work offers insights into how these elements interact and influence health outcomes, reflecting a comprehensive approach to genetic research.

Aliases

Christos Shammas is also known by the aliases C Shammas and C. Shammas in various academic publications. These aliases might be used interchangeably in different contexts, reflecting the common practice of using initials in scientific authorship.

Publication and Citation Metrics

Metric	Value
Citation Count	384
H-index	13
Paper Count	48

Publications:

Evolution of prokaryotic colonisation of greenhouse plastics discarded into the environment.

DOI: 10.1016/j.ecoenv.2022.113213

Year: 2022

Bifidobacterium Is Enriched in Gut Microbiome of Kashmiri Women with Polycystic Ovary Syndrome

DOI: 10.3390/genes13020379

Year: 2022

Treatment of nasal inflammation in children using azithromycin alone or combined with lactulose.

DOI: 10.1186/isrctn14790675

Year: 2019

Bifidobacterium is enriched in gut microbiome of Kashmiri women with polycystic ovary syndrome

DOI: 10.1101/718510

Year: 2019

Intestinal microbiome analysis demonstrates azithromycin post-treatment effects improve when combined with lactulose

DOI: 10.1007/s12519-019-00315-6

Year: 2019

Variations in the 3′UTR of the CYP21A2 Gene in Heterozygous Females with Hyperandrogenaemia

DOI: 10.1155/2017/8984365

Year: 2017

CDKN2A and MC1R variants found in Cypriot patients diagnosed with cutaneous melanoma

DOI: 10.1007/s12041-017-0742-6

Year: 2017

Genetic screening of non-classic CAH females with hyperandrogenemia identifies a novel CYP11B1 gene mutation

DOI: 10.14310/horm.2002.1651

Year: 2016

In silico analysis of a novel MKRN3 missense mutation in familial central precocious puberty

DOI: 10.1111/cen.12854

Year: 2016

MKRN3 Mutations and Central Precocious Puberty

DOI:

Year: 2016

What is the Future of CFTR Gene Research?

Can the body repair PAH-induced DNA damage?

How do Viral Vectors Work?

Why is Prenatal Screening Important?

What are Biological Agents that Induce Mutations?

What is Gene Amplification?

Are There Risks of Genetic Mutations in Sickle Cell Patients Using Hydroxyurea?

Can Mutagens Be Prevented?

What Are the Limitations of Sanger Sequencing?

What is CRISPR Technology?

Partnered Content Networks

Relevant Topics